Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB-NOLI vs RUCAPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB-NOLI vs RUCAPARIB: Safety Overview

Metric ROZANOLIXIZUMAB-NOLI RUCAPARIB
Total FAERS Reports 349 434
Deaths Reported 4 50
Death Rate 1.1% 11.5%
Hospitalizations 84 310
Average Patient Age 55.1 yrs 64.3 yrs
% Female Patients 63.3% 69.5%
Marketing Status Prescription N/A